2 not yet recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Doxorubicin Adverse Reaction: new trials by email Literature Review of Doxorubicin Adverse Reaction trials Research Report on Doxorubicin Adverse Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma Acupuncture - Febrile Neutropenia, Sarcoma | Not applicable | Not yet recruiting | Shaare Zedek Medical Center | 60 | 2026-12-01 | 2026-04-29 |
| The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Nicorandil Oral Tablet, Adriamycin (Doxorubicin) - Doxorubicin Induced Cardiotoxicity, Doxorubicin Induced Cardiomyopathy | Phase 2 | Not yet recruiting | Universiti Sains Malaysia | 146 | 2026-12-01 | 2026-11-03 |
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients Control group:DH001 placebo, Trial group: DH001 low-dose group, Trial group: DH001 high-dose group - Cancer, Heart Failure | Phase 2 | Unknown | Monyan Pharmaceutical (Shanghai) Co., Ltd. | 90 | 2023-04-04 | 2023-10-23 |
| The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor Doxorubicin Adverse Reaction, Cardiomyopathies, Secondary | Completed | Rush University Medical Center | 42 | 2017-01-17 | 2021-04-27 |
Cardiomyopathies (2) · Heart Failure (2) · Arrhythmias, Cardiac (1) · Breast Neoplasms (1) · Cardiotoxicity (1) · Cross Infection (1) · Febrile Neutropenia (1) · Neoplasms (1) · Sarcoma (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Neoplasms (2) · Agranulocytosis (1) · Breast Diseases (1) · Chemically-Induced Disorders (1) · Cytopenia (1) · Disease Attributes (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Iatrogenic Disease (1) · Infections (1)
Acupuncture Therapy (1) · Control Groups (1) · Doxorubicin (1) · Nicorandil (1) · Population Groups (1)
Monyan Pharmaceutical (Shanghai) Co., Ltd. (1) · Rush University Medical Center (1) · Shaare Zedek Medical Center (1) · Universiti Sains Malaysia (1)
China (1) · Egypt (1) · Israel (1) · United States (1)
Ayman A G, Prof (1) · Hesheng He (1) · Hongmei Jing (1) · Hui Zhou (1) · Jiwei Liu (1) · Jun Zhu (1) · Noah Samuels, MD (1) · Noha S Abdelaziz, PhD (1) · Nur H Md, lecturer (1) · Sabariah N H, Ass.Prof (1) · Tochi Okwuosa, DO, FACC (1) · Wenbin Qian (1) · Xiaojia Wang (1) · Yufu Li (1) · Zeping Zhou (1)